Catherine C. Turkel Lexaria Bioscience Corp. (LEXX) insider trading activity

LEXX Quotes by TradingView

Catherine C. Turkel is Director of Lexaria Bioscience Corp.. Currently has a direct ownership of 3,100 shares of LEXX, which is worth approximately $5,394. The most recent transaction as insider was on Aug 12, 2024, when has been sold 1,600 shares (Common Shares) at a price of $3.13 per share, resulting in proceeds of $5,008. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.1K
0% 3M change
106.67% 12M change
Total Value Held $5,394

CATHERINE C. TURKEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2024
BUY
Open market or private purchase
$5,008 $3.13 p/Share
1,600 Added 34.04%
3,100 Common Shares
Feb 09 2023
BUY
Open market or private purchase
$4,260 $2.84 p/Share
1,500 Added 50.0%
1,500 Common Shares
CCT

Catherine C. Turkel

Director
Irvine, CA

Track Institutional and Insider Activities on LEXX

Follow Lexaria Bioscience Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEXX shares.

Notify only if

Insider Trading

Get notified when an Lexaria Bioscience Corp. insider buys or sells LEXX shares.

Notify only if

News

Receive news related to Lexaria Bioscience Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LEXX